Investor Presentation Q2FY23

TOP 10 Countries: Export Sale of APIs & Formulations Q2FY23 Export Formulation Sales - 58Crs 13% 2% 3% 3% 3% 3% 4% 4% 5% 5% Source: Internal Data 55% USA 21% New Zealand UK Chile Malaysia 4% Kathmandu 4% Ethiopia Myanmar PRESSREA 4% Tanzania Zimbabwe Others 5% Export API Sales - 17crs 7% 9% 7% 16% Germany Japan USA Saudi Arabia Turkey 14% Algeria South Korea Taiwan Australia 9% France ■Others 2 (b) FDC

View entire presentation